In 2014, an Intrathecal Chemotherapy Project Board was established to develop recommendations on intrathecal chemotherapy and neurotoxic drugs, in response to Recommendation 71 of the NCCP Oncology Medication Safety Review.
The Intrathecal Chemotherapy Project Board produced four guidance documents, which were endorsed by the Oncology Medication Review Implementation Steering Group in November 2015.
The documents are available below:
NCCP Guidance on the Use of Intrathecal Chemotherapy in the Treatment of Cancer
NCCP Guidance on the Use of Neurotoxic Drugs (including Vinca Alkaloids) in the Treatment of Cancer